Prognostic Factors in Renal Cell Carcinoma

Thrasher JB Paulson DF Prognostic factors in renal cancer. Urol Clin North Am 1993;20:247–262.

Hoffman DM Gitlitz BJ Belldegrun A Figlin RA Adoptive cellular therapy. Semin Oncol 2000;27:221–233.

Favrot MC Puisieux I Application of gene transfer in cancer immunotherapy. From experimental data to clinical protocols. Adv Exp Med Biol 1998; 451: 539–541.

Hoos A Levey DL Vaccination with heat shock protein-peptide complexes: From basic science to clinical applications. Expert Rev Vaccines 2003;2:369–379.

Childs R Chernoff A Regression of metastatic renal-cell carcinoma. NEJM 2000;343:75–758.

Jonas D Thoma B Beckert H Weber W The value of morphological prognostic criteria in the assessment of renal cell carcinoma. Urol Int 1985;40:48–154.

Thönes W Störkel S Rumpelt HJ . Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas): The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 1986; 181: 125–143.

Kovacs G Wilkens L Papp T de Riese W Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis. J Nat Cancer Inst 1989;81:527–530.

Kovacs G Molecular cytogenetics of renal cell tumors. Adv Cancer Res 1993;62:89–124.

Kovacs G Akhtar M Beckwith BJ Bugert P Cooper CS Delahunt B Eble JN Fleming S Ljungberg B Medeiros LJ Moch H Reuter VE Ritz E Roos G Schmidt D Srigley JR Störkel S Vandenberg E Zbar B The Heidelberg classification of renal cell tumours. J Pathol 1997;183:131–133.

Störkel S Eble JN Adlakha K Amin M Blute ML Bostwick DG Darson M Delahunt B Iczkowski K Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997; 80: 987–989.

Beck SD Patel MI Snyder ME Kattan MW Motzer RJ Reuter VE Russo P Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol 2004;11:71–77.

Amin MB Amin MB Tamboli P Javidan J Stricker H de Venturina Peralta M Deshpande A Menon M Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: An experience of 405 cases. Am J Surg Pathol 2002;26:281–291.

Ljungberg B Alamdari FI Stenling R Roos G Prognostic significance of the Heidelberg classification of renal cell carcinoma. Eur Urol 1999;36:565–569.

Amin MB Corless CL Renshaw AA Tickoo SK Kubus J Schultz DS Papillary (chromophil) renal cell carcinoma: Histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol 1997;21:621–635.

Mancilla-Jimenez R Stanley RJ Blath RA Papillary renal cell carcinoma: A clinical, radiologic, and pathologic study of 34 cases. Cancer 1976;38:2469–2480.

Moch H Gasser T Amin MB Torhorst J Sauter G Mihatsch MJ Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: A Swiss experience with 588 tumors. Cancer 2000;89:604–614.

Crotty TB Farrow GM Lieber MM Chromophobe cell renal carcinoma: Clinicopathological features of 50 cases. J Urol 1995;154:964–967.

Srigley JR Eble JN Collecting duct carcinoma of kidney. Semin Diagn Pathol 1998;15:54–67.

Schullerus D Herbes J Chudek J Kanamaru H Kovacs G Loss of heterozygosity at chromosomes 8p, 9p and 14q is associated with stage and grade of nonpapillary renal cell carcinomas. JPathol 1997;183:151–155.

Presti JC Jr Wilhelm M Reuter V Russo P Motzer R Waldman F Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney. J Urol 2002;167:1464–1468.

Jiang F Richter J Schraml P Bubendorf L Gasser T Sauter G Mihatsch MJ Moch H Chromosomal imbalances in papillary renal cell carcinoma: Genetic differences between histological subtypes. Am J Pathol 1998;153:1467–1473.

Childs RW Nonmyeloablative blood stem cell transplantation as adoptive allogeneic immunotherapy for metastatic renal cell carcinoma. Crit Rev Immunol 2001;21:191–203.

Skinner DG Colvin RB Vermillion CD Pfister RC Leadbetter WF Diagnosis and management of renal cell carcinoma. A clinical and pathological study of 309 cases. Cancer 1971; 28: 1165–1177.

Ljungberg B Iranparar Alamdari F Rasmuson T Roos G Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. Br J Urol 1999;84:405–411.

Guinan P Sobin LH Algaba F Badellino F Kameyama S MacLennan G Novick A TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997; 80: 992–993.

Gettman MT Blute ML Spotts B Bryant SC Zincke H Pathologic staging of renal cell carcinoma: Significance of tumor classification with the 1997 TNM staging system. Cancer 2001; 91:354–361.

Butler BP Novick AC Miller DP Campbell SA Licht MR Management of small unilateral renal cell carcinomas: Radical versus nephron-sparing surgery. Urology 1995; 45: 34–40; discussion 40–41.

Javidan J Stricker HJ Tamboli P Amin MB Peabody JO Deshpande A Menon M Amin MB Prognostic significance of the 1997 TNM classification of renal cell carcinoma. J Urol 1999;162:1277–1281.

Sobin LH Wittekind CH International Union Against Cancer (UICC). TNM classification of malignant tumours. 6th Ed. New York: 2002: 193–195.

Han KR Bui MH Pantuck AJ Freitas DG Leibovich BC Dorey FJ Zisman A Janzen NK Mukouyama H Figlin RA Belldegrun AS TNM T3a renal cell carcinoma: Adrenal gland involvement is not the same as renal fat invasion. J Urol 2003; 169: 899–903; discussion 903–904.

Fiori E de Cesare A Galati G Bononi M D'Andrea N Barbarosos A Izzo L Bolognese A Prognostic significance of primary-tumor extension, stage and grade of nuclear differentiation in patients with renal cell carcinoma. J Exp Clin Cancer Res 2002;21:229–232.

Ljungberg B Stenling R Österdahl B Farrelly E Åberg T Roos G Vein invasion in renal cell carcinoma: Impact on metastatic behaviour and survival. J Urol 1995;154:1681–1684.

Zisman A Wieder JA Pantuck AJ Chao DH Dorey F Said JW Gitlitz BJ DeKernion JB Figlin RA Belldegrun AS Renal cell carcinoma with tumor thrombus extension: Biology, role of nephrectomy and response to immunotherapy. J Urol 2003;169:909–916.

Uzzo RG Cherullo EE Myles J Novick AC Renal cell carcinoma invading the urinary collecting system: Implications for staging. J Urol 2002;167:2392–2396.

Palapattu GS Pantuck AJ Dorey F Said JW Figlin RA Belldegrun AS Collecting system invasion in renal cell carcinoma: Impact on prognosis and future staging strategies. J Urol 2003; 170: 768–772; discussion 772.

Motzer RJ Bander NH Nanus DM Renal-cell carcinoma: N Engl J Med 1996; 335: 865–875.

Bretheau D Lechevallier E de Fromont M Sault MC Rampal M Coulange C Prognostic value of nuclear grade of renal cell carcinoma. Cancer 1995;76:2543–2549.

Ficarra V Righetti R Pilloni S D'amico A Maffei N Novella G Zanolla L Malossini G Mobilio G Prognostic factors in patients with renal cell carcinoma: Retrospective analysis of 675 cases. Eur Urol 2002;41:190–198.

Ruiz JL Hernandez M Martinez J Vera C Jimenez-Cruz JF Value of morphometry as an independent prognostic factor in renal cell carcinoma. Eur Urol 1995;27:54–57.

Carducci MA Piantadosi S Pound CR Epstein JI Simons JW Marshall FF Partin AW Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma. Urology 1999;53:44–49.

Frank I Blute ML Cheville JC Lohse CM Weaver AL Zincke H An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score. J Urol 2002;168:2395–2400.

Frank I Blute ML Cheville JC Lohse CM Weaver AL Leibovich BC Zincke H A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma. J Urol 2003;170:2225–2232.

Ljungberg B Mehle C Stenling R Roos G Heterogeneity in renal cell carcinoma and its impact on prognosis — A flow cytometric study. Br J Cancer 1996;74:123–127.

Di Silverio F Casale P Colella D Andrea L Seccareccia F Sciarra A Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma. Cancer 2000;88:835–843.

Sringley JR Srigley JR Hutter RV Gelb AB Henson DE Kenney G King BF Raziuddin S Pisansky TM Current prognostic factors — Renal cell carcinoma: Workgroup No. 4. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997; 80: 994–996.

Larsson P Roos G Stenling R Ljungberg B Proliferating cell nuclear antigen expression in renal cell carcinoma — Prognostic implications. Scand J Urol Nephrol 1996;30:445–450.

Larsson P Roos G Stenling R Ljungberg B Proliferation of human renal cell carcinoma studied with in vivo iododeoxyuridine labelling and immunohistochemistry. Scand J Urol Nephrol;8:135–140.

Rioux-Leclercq N Epstein JI Bansard JY Turlin B Patard JJ Manunta A Chan T Ramee MP Lobel B Moulinoux JP Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma. Hum Pathol 2001;32:1209–1215.

Renshaw AA Loughlin KR Dutta A Cyclin A and MIB1 (Ki67) as markers of proliferative activity in primary renal neoplasms. Mod Pathol 1998;11:96396–6.

Rioux-Leclercq N Turlin B Bansard J Patard J Manunta A Moulinoux JP Guille F Ramee MP Lobel B Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma. Urology 2000;55:501–505.

Hedberg Y Ljungberg B Roos G Landberg G Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray. Br J Cancer 2003;88:1417–1423.

Aaltomaa S Lipponen P Ala-Opas M Eskelinen M Syrjänen K Kosma VM Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Br J Cancer 1999;80:2001–2007.

Migita T Oda Y Naito S Tsuneyoshi M Low expression of p27 (Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma. Cancer 2002;94:973–979.

Hedberg Y Davoodi E Ljungberg B Roos G Landberg G Cyclin E and p27 protein content in human renal cell carcinoma: Clinical outcome and associations with cyclin D. Int J Cancer 2002;102:601–607.

Folkman J Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27–31.

Wiesener MS Munchenhagen PM Berger I Morgan NV Roigas J Schwiertz A Jurgensen JS Gruber G Maxwell PH Loning SA Frei U Maher ER Grone HJ Eckardt KU Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Cancer Res 2001;61:5215–5222.

Jacobsen J Rasmuson T Grankvist K Ljungberg B Vascular endothelial growth factor as prognostic factor in renal cell carcinoma. J Urol 2000;163:343–347.

Ljungberg B Jacobsen J Häggström S Rasmuson T Lindh G Grankvist K Tumor Vascular Endothelial Growth Factor (VEGF) mRNA in relation to serum VEGF protein levels and tumor progression in human renal cell carcinoma. Urol Res 2003;31:335–340.

Moch H Sauter G Gasser TC Buchholz N Bubendorf L Richter J Jiang F Dellas A Mihatsch MJ P53 protein expression but not mdm-2 protein expression is associated with rapid tumor cell proliferation and prognosis in renal cell carcinoma. Urol Res 1997;25:S25–30.

Uchida T Gao JP Wang C Jiang SX Muramoto M Satoh T Minei S Shimura S Irie A Kameya T Baba S Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma. Urology 2002;59:615–620.

Ljungberg B Bozoky B Kovacs G Stattin P Farrelly E Nylander K Landberg G P53 expression in correlation to clinical outcome in patients with renal cell carcinoma. Scand J Urol Nephrol 2001;35:15–20.

Huang A Fone PD Gandour-Edwards R White RW Low RK Immunohistochemical analysis of BCL-2 protein expression in renal cell carcinoma. J Urol 1999;162:610–613.

Ljungberg B Österdahl B Mehle C Clinical significance of nm23 expression in renal cell carcinoma. Urol Res 1999;27:103–107.

Hofmockel G Riess S Bassukas ID Dammrich J Epidermal growth factor family and renal cell carcinoma: Expression and prognostic impact. Eur Urol 1997;31:478–484.

Stumm G Eberwein S Rostock-Wolf S Stein H Pomer S Schlegel J Waldherr R Concomitant overexpression of the EGFR and erbB-2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis. Int J Cancer 1996: 20; 69: 17–22.

Rasmuson T Grankvist K Ljungberg B Soluble ectodomain of c-erbB-2 oncoprotein in relation to tumour stage and grade in human renal cell carcinoma. Br J Cancer 1997;75:1674–1677.

Murakami Y Kanda K Tsuji M Kanayama H Kagawa S MN/CA9 gene expression as a potential biomarker in renal cell carcinoma. BJU Int 1999;83:743–747.

Patard JJ Leray E Rodriguez A Rioux-Leclercq N Guille F Lobel B Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma. Eur Urol 2003;44:226–232.

Abou Fettouh HI El Cherullo EE El-Jack M Al Maslamani Y Novick AC Sporadic renal cell carcinoma in young adults: Presentation, treatment, and outcome. Urology 2002;60:806–810.

Kim HL Belldegrun AS Freitas DG Bui MH Han KR Dorey FJ Figlin RA Paraneoplastic signs and symptoms of renal cell carcinoma: Implications for prognosis. J Urol 2003;170:1742–1746.

Pantuck AJ Zisman A Rauch MK Belldegrun A Incidental renal tumors. Urology 2000;56:190–196.

Tsui KH Shvarts O Smith RB Figlin RA DeKernion JB Belldegrun A Prognostic indicators for renal cell carcinoma: A multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 2000;163:1090–1095.

Ljungberg B Landberg G Alamdari F Factors of importance for prediction of survival in patients with metastatic renal cell carcinoma, treated with or without nephrectomy. Scand J Urol Nephrol 2000;34:246–251.

Schips L Lipsky K Zigeuner R Salfellner M Winkler S Langner C Rehak P Pummer K Hubmer G Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: A single-center experience of 683 patients. Urology 2003;62:1024–1028.

Ljungberg B Grankvist K Rasmuson T Serum acute phase reactants and prognosis in renal cell carcinoma. Cancer 1995;76:1435–1439.

Roosen JU Engel U Jensen RH Kvist E Schou G Renal cell carcinoma: Prognostic factors. Br J Urol 1994;74:160–164.

Dosquet C Coudert MC Lepage E Cabane J Richard F Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma? Clin Cancer Res 1997;3:2451–2458.

Rasmuson T Grankvist K Roos G Ljungberg B Neuroendocrine differentiation in renal cell carcinoma — Evaluation of chromogranin A and neuron-specific enolase. Acta Oncol 1999; 38:623–628.

Ljungberg B Rasmuson T Grankvist K Erythropoietin in renal cell carcinoma: Evaluation of its usefulness as a tumor marker. Eur Urol 1992;21:160–163.

Ljungberg B Grankvist K Ljungberg B Rasmuson T Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma. Int J Cancer 1997;74:233–236.

Mickisch GH Garin A van Poppel H de Prijck L Sylvester R EORTC Genitourinary Group. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: A randomised trial. Lancet 2001;358:966–970.

Flanigan RC Salmon SE Blumenstein BA Bearman SI Roy V McGrath PC Caton JR Jr Munshi N Crawford ED Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 2001; 345: 1655–1659.

van der Poel HG Roukema JA Horenblas S van Geel AN Debruyne FM Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis. Eur Urol 1999;35:197–203.

Pfannschmidt J Hoffmann H Muley T Krysa S Trainer C Dienemann H Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 2002;74:1653–1657.

Tanguay S Pisters LL Lawrence DD Dinney CP Therapy of locally recurrent renal cell carcinoma after nephrectomy. J Urol 1996;155:26–29.

Schlichter A Wunderlich H Junker K Kosmehl H Zermann DH Schubert J Where are the limits of elective nephron-sparing surgery in renal cell carcinoma? Eur Urol 2000;37:517–520.

Fergany AF Hafez KS Novick AC Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 2000;163:442–445.

Kattan MW Reuter V Motzer RJ Katz J Russo P A postoperative prognostic nomogram for renal cell carcinoma. J Urol 2001;166:63–67.

Zisman A Pantuck AJ Dorey F Said JW Shvarts O Quintana D Gitlitz BJ DeKernion JB Figlin RA Belldegrun AS Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 2001;19:1649–1657.

Zisman A Pantuck AJ Wieder J Chao DH Dorey F Said JW DeKernion JB Figlin RA Belldegrun AS Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 2002; 20: 4559–4566.

Griffiths DF Verghese A Golash A Kynaston HG Matthews PN Hart AJ Court JB . Contribution of grade, vascular invasion and age to outcome in clinically localized renal cell carcinoma. BJU Int 2002 90: 26–31.